Indian Journal of Medical Microbiology Home 

CORRESPONDENCE
[Download PDF]
Year : 2014  |  Volume : 32  |  Issue : 1  |  Page : 97--98

Multidrug resistant Gram-negative bacilli from neonatal septicaemia at a tertiary care centre in North India: A phenotypic and genotypic study

R Srivastava1, J Agarwal1, S Srivastava1, M Kumar1, M Singh2,  
1 Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India
2 Department of Pediatrics, King George's Medical University, Lucknow, Uttar Pradesh, India

Correspondence Address:
J Agarwal
Department of Microbiology, King George«SQ»s Medical University, Lucknow, Uttar Pradesh
India

How to cite this article:
Srivastava R, Agarwal J, Srivastava S, Kumar M, Singh M. Multidrug resistant Gram-negative bacilli from neonatal septicaemia at a tertiary care centre in North India: A phenotypic and genotypic study.Indian J Med Microbiol 2014;32:97-98

How to cite this URL:
Srivastava R, Agarwal J, Srivastava S, Kumar M, Singh M. Multidrug resistant Gram-negative bacilli from neonatal septicaemia at a tertiary care centre in North India: A phenotypic and genotypic study. Indian J Med Microbiol [serial online] 2014 [cited 2020 Jul 16 ];32:97-98
Available from: http://www.ijmm.org/text.asp?2014/32/1/97/124352

Full Text

Dear Editor,

Neonatal septicaemia is a leading cause of morbidity and mortality in developing countries. Prompt treatment with appropriate antibiotics is necessary to reduce mortality and complications. [1] In an attempt to know the antibiotic resistance and prevalent mechanisms amongst Gram-negative bacilli (GNB) associated with neonatal septicaemia, 1474 (non-repetitive) blood culture samples from Neonatal Unit and Neonatal Intensive Care Unit collected between July 2011 and June 2012 were prospectively analysed. Antimicrobial susceptibility and screening/confirmatory tests for extended spectrum β-lactamase (ESBL) were performed as per Clinical Laboratory Standards Institute guidelines. [2] Metallo β-lactamase (MBL) production by ethylenediaminetetraacetic acid disc synergy test (EDST), [3] minimum inhibitory concentration (MIC) for meropenem and colistin, [2] phenotypic tests for AmpC production (by cefoxitin disc, [3] disc antagonism test, [3] boronic acid inhibition test [4] and ceftazidime-imipenem antagonism test) [5] and test for presence of efflux pump were performed. [6] Multiplex polymerase chain reaction (PCR) for CTX-M gene 1, 2, 8, 9 and 25 [7] and bla IMP-1 , bla IMP-2 , bla VIM-1 and bla VIM-2 of carbapenemases genes were done. [6]

A total of 273 (non-repetitive) bacterial isolates were obtained; comprising coagulase negative staphylococci (38.4%), Acinetobacter baumannii (16.4%), Staphylococcus aureus (15.7%), Klebsiella pneumoniae (9.1%), Candida sp. (6.2%), Pseudomonas aeruginosa (6.5%), Escherichia coli (4.7%), Citrobacter freundii (1.8%) and Enterobacter cloacae (0.73%). From amongst 108 GNB isolated, quarter were multidrug resistant (MDR; resistance to >3 groups of antibiotics). 48/108 GNB (44.4%) were meropenem resistant, MIC for these ranged between 4 and 28 μg/ml; isolates with higher MIC showed the presence of efflux pump. There were 33 ESBL producers and 34 were positive by EDST; 12 were both ESBL and MBL producers. Only one P. aeruginosa isolate produced AmpC (boronic acid inhibition test). Five P. aeruginosa (MIC ≥ 8 μg/ml) and 10 A. baumanii (MIC ≥ 4 μg/ml) were resistant to colistin. CTX-M-Group 1 was present in 17 GNB isolates, bla IMP-1 and bla VIM-2 in 9 and 2 isolates respectively, with one isolate carrying both the genes. In our study, EDST failed to detect all MBL producers as shown by PCR [Table 1].{Table 1}

Reports from developing countries show GNB to be the major etiological agents (~60%) of neonatal sepsis with K. pneumoniae being most common. [1] In our study however, A. baumannii was the most common GNB (45/108; 41.6%) with Gram-positive cocci in overall majority. Coexistence of various resistance mechanism including production of ESBL, MBL and AmpC β-lactamases and efflux pumps have led to MDR status amongst bacteria. [8] In the present study, one-fourth of the GNB isolated were MDR and ESBL prevalence was 30.5%, studies however have reported up to 72% ESBL producers in amongst GNB causing neonatal sepsis from India. [9] AmpC β-lactamase does not seem to be a major resistance mechanism in our setting. Colistin resistance seems to be higher amongst P. aeruginosa and A. baumannii at our centre. 31.5% GNB were MBL producers; much higher than what has been reported earlier. [8] In the present study, more than half of the ESBL producers carried CTX-M Group 1. The three C. freundii isolates were all MDR and carried CTX-M gene, a finding reported from other countries as well in recent years. [10]

In conclusion, we have highlighted changes in the bacterial aetiology of neonatal septicaemia, with non-fermenters emerging as important pathogens. Overall, prevalence of β-lactamases was low in our setting but closely linked to MDR status. It is important to understand local epidemiology for better implementation of infection control policies.

References

1Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet 2005;365:1175-88.
2Clinical Laboratory Standards Institute (CLSI) Guidelines. Performance standards for antimicrobial susceptibility testing: 21 st Informational Supplement. CLSI Document M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
3Upadhyay S, Sen MR, Bhattacharjee A. Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase enzyme. J Infect Dev Ctries 2010;4:239-42.
4Upadhyay S, Sen MR, Bhattacharjee A. Diagnostic utility of boronic acid inhibition with different cephalosporins against Escherichia coli producing AmpC β-lactamases. J Med Microbiol 2011;60:691-3.
5Cantarelli VV, Inamine E, Brodt TC, Secchi C, Cavalcante BC, Pereira Fde S. Utility of the ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC beta-lactamases among enterobacteriaceae. Braz J Infect Dis 2007;11:237-9.
6Sinha N, Agarwal J, Srivastava S, Singh M. Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India. Indian J Med Microbiol 2013;31:60-3.
7Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 2006;57:154-5.
8Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL and Ampc β lactamases producing superbugs-Havoc in the intensive care units of Punjab India. J Clin Diagn Res 2013;7:70-3.
9Wattal C, Oberoi JK. Neonatal sepsis. Indian J Pediatr 2011;78:473-4.
10Millán B, Ghiglione B, Díaz T, Gutkind G, Araque M. CTX-M-14 β-lactamase-producing Citrobacter freundii isolated in Venezuela. Ann Clin Microbiol Antimicrob 2011;10:22.